Safety Study of TAK-700 in Subjects With Prostate Cancer.
Status:
Completed
Trial end date:
2013-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and tolerability of TAK-700 in patients
with asymptomatic metastatic, androgen independent prostate cancer.